The impact of dementia on the family

PV Rabins, NL Mace, MJ Lucas - Jama, 1982 - jamanetwork.com
To determine the impact of dementia on the family, we interviewed the primary care givers
of 55 patients suffering from an irreversible dementia. Problems reported included …

Common variable immunodeficiency disorders: division into distinct clinical phenotypes

H Chapel, M Lucas, M Lee, J Bjorkander… - Blood, The Journal …, 2008 - ashpublications.org
The European Common Variable Immunodeficiency Disorders registry was started in 1996
to define distinct clinical phenotypes and determine overlap within individual patients. A total …

Mortality in systemic sclerosis: an international meta-analysis of individual patient data

…, AB Haidich, TA Medsger Jr, M Lucas… - The American journal of …, 2005 - Elsevier
PURPOSE: Studies on mortality associated with systemic sclerosis have been limited by
small sample sizes. We aimed to obtain large-scale evidence on survival outcomes and …

Infection outcomes in patients with common variable immunodeficiency disorders: relationship to immunoglobulin therapy over 22 years

M Lucas, M Lee, J Lortan, E Lopez-Granados… - Journal of Allergy and …, 2010 - Elsevier
BACKGROUND: Common variable immunodeficiency disorders (CVIDs) are the most
common forms of symptomatic primary antibody failure in adults and children. Replacement …

Systemic sclerosis sine scleroderma: demographic, clinical, and serologic features and survival in forty‐eight patients

H Poormoghim, M Lucas, N Fertig… - … : Official Journal of the …, 2000 - Wiley Online Library
Objective To describe the demographic, clinical, and laboratory features and natural history
of patients with systemic sclerosis sine scleroderma (ssSSc), and to compare them with …

Anti–signal recognition particle autoantibody in patients with and patients without idiopathic inflammatory myopathy

AH Kao, D Lacomis, M Lucas, N Fertig… - … : Official Journal of the …, 2004 - Wiley Online Library
Objective To determine the long‐term outcome and associated clinical, serologic, and
pathologic features in a cohort of patients with connective tissue disease (CTD) and the anti–…

Patients with non-Jo-1 anti-tRNA-synthetase autoantibodies have worse survival than Jo-1 positive patients

…, E Cassidy, N Fertig, DC Koontz, M Lucas… - Annals of the …, 2014 - ard.bmj.com
Objective To compare the cumulative survival and event free survival in patients with Jo-1
versus non-Jo-1 anti-tRNA synthetase autoantibodies (anti-synAb). Methods Anti-synAb …

Treatment of antisynthetase‐associated interstitial lung disease with tacrolimus

…, SM Sereika, N Fertig, MR Lucas… - … : Official Journal of …, 2005 - Wiley Online Library
Objective To assess the efficacy of tacrolimus in patients with anti–aminoacyl–transfer RNA
synthetase (anti‐aaRS)–associated interstitial lung disease (ILD) and idiopathic …

Replication and validation of anticipated turnover model for urban registered nurses

MD Lucas, JR Atwood, R Hagaman - Nursing Research, 1993 - journals.lww.com
Replication of the Anticipated Turnover Model Among Nurses for urban registered nurses
provided substantial support for the stability and generalizability of the theoretical model. In …

Anti–Jo‐1 antibody levels correlate with disease activity in idiopathic inflammatory myopathy

…, N Fertig, Y Katsumata, M Lucas… - … : Official Journal of …, 2007 - Wiley Online Library
Objective Previous case series have examined the relationship between anti–Jo‐1 antibody
levels and myositis disease activity, demonstrating equivocal results. Using enzyme‐linked …